Y-Intercept (HK)
RYTM icon

Y-Intercept (HK)’s Rhythm Pharmaceuticals RYTM Stock Holding History

Y-Intercept (HK)’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-7,925
Closed -$880K – 2031
2026
Q2 		$880K Buy
+7,925
New +$717K 0.02% 1098
2025
Q2 		– Sell
-5,966
Closed -$316K – 1964
2025
Q1 		$316K Buy
5,966
+100
+2% +$5.55K 0.02% 888
2024
Q4 		$328K Buy
+5,866
New +$324K 0.02% 905

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
iA Global Asset Management
iA Global Asset Management Quebec, Quebec, Canada $8.54B AUM 39.73% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Cannon Financial Strategists
Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Y-Intercept (HK)'s RYTM Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2026, closing a stake of 7,925 shares — an estimated $880K sold.

Y-Intercept (HK) first reported a position in RYTM in Q4 2024 and held it in 3 quarters. The position peaked at $880K in Q2 2026. 62 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Rhythm Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 7,925 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $880K.
  • Y-Intercept (HK) first reported a position in Rhythm Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Y-Intercept (HK)'s Rhythm Pharmaceuticals position peaked at $880K in Q2 2026.
  • 62 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.